Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-20

Clinical Trial Update: The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of combining oral contraceptives with metformin on clinical, hormonal, metabolic, and ultrasonographic characteris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined oral contraceptives (OCP) (combined oral contraceptives)
  • metformin (metformin)

Snippet

Sponsor: S.C.B. Medical College and Hospital | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED